Nephros Inc (NEPH) Stock Price, Quote & News

Company Profile

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilitie...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 343 5202

Website: www.nephros.com

Address:

380 Lackawanna Place, South Orange, United States

abc12379593827 Mar. 15 at 3:34 PM

$AIFF $BIAF $IPM $NEPH $AIB Just so you are all aware, the one stock that should be on EVERYONE’s watchlist for Monday, isn’t on this list. I’ll tell you what it is after I buy a lot more shares.

0 · Reply

NathanWolffe Mar. 15 at 2:02 PM

Watchlist monday: $AIB $NEPH $BIAF $IPM 🏆 $AIFF

0 · Reply

johnjaha Mar. 14 at 9:13 PM

$AIFF $BIAF $IPM $NEPH $AIB SRXH

1 · Reply

NathanWolffe Mar. 14 at 8:59 PM

Watchlist monday: $AIB $NEPH $BIAF $IPM 🏆 $AIFF

0 · Reply

NathanWolffe Mar. 14 at 5:00 AM

Next week watchlist: $AIB Will fill back the gap to 0.70$ after it scooped retail panic selling. $NEPH looks good for continuation $IPM cybersecurity will be the next theme, many catalysts coming up on this low float $DEVS Lets see if they run it back up $IOBT Penny trend

0 · Reply

StocktwitsEarnings Mar. 12 at 8:09 PM

$NEPH Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.01 down -66.67% YoY • Reported revenue of $4.73M up 22.20% YoY • Nephros anticipates that its cash balances will be sufficient to fund its current operating plan through at least the next 12 months from the date of issuance of this Annual Report on Form 10-K.

0 · Reply

OfficialStocktwitsUser Mar. 2 at 7:45 PM

$NEPH RSI: 50.11, MACD: -0.1406 Vol: 0.19, MA20: 3.99, MA50: 4.45 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 27 at 12:00 AM

$NEPH Current Stock Price: $4.01

0 · Reply

VolatilitySurface Feb. 17 at 12:23 PM

$NEPH Pre-revenue medtech; early-stage renal or dialysis focus.

0 · Reply

candletom Feb. 17 at 8:03 AM

$NEPH Micro-cap medtech or biotech; speculative

0 · Reply

Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results

Mar 5, 2026, 7:04 AM EST - 16 days ago

Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call

Oct 30, 2025, 4:00 PM EDT - 5 months ago

Nephros Schedules Third Quarter 2025 Financial Results Conference Call

Aug 7, 2025, 4:00 PM EDT - 8 months ago

Nephros Announces Strong Second Quarter Financial Results

Jul 31, 2025, 4:00 PM EDT - 8 months ago

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

Oct 31, 2024, 7:30 AM EDT - 1 year ago

Nephros Schedules Third Quarter 2024 Financial Results Conference Call

Oct 17, 2024, 9:00 AM EDT - 1 year ago

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Nephros Announces Financial Results for Quarter Ended June 30, 2024

Aug 1, 2024, 7:30 AM EDT - 1 year ago

Nephros Schedules Second Quarter 2024 Financial Results Conference Call

Mar 7, 2024, 4:15 PM EST - 2 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 29, 2024, 4:30 PM EST - 2 years ago

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Nov 8, 2023, 4:15 PM EST - 2 years ago

Nephros Announces Results for Quarter Ended September 30, 2023

Nov 1, 2023, 7:30 AM EDT - 2 years ago

Nephros Hires Judy Krandel as Chief Financial Officer

Oct 25, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules Third Quarter 2023 Financial Results Conference Call

Sep 19, 2023, 4:30 PM EDT - 2 years ago

Nephros to Present at LD Micro Main Event XVI

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended June 30, 2023

Jul 26, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

May 24, 2023, 7:30 AM EDT - 3 years ago

Nephros to Present at LD Micro Invitational XIII

May 10, 2023, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended March 31, 2023

May 8, 2023, 7:30 AM EDT - 3 years ago

Nephros Announces CEO Retirement and Succession Plan

Apr 26, 2023, 7:30 AM EDT - 3 years ago

Nephros Schedules First Quarter 2023 Financial Results Conference Call

Apr 4, 2023, 7:30 AM EDT - 3 years ago

Nephros Announces Preliminary Results for First Quarter 2023

Mar 8, 2023, 4:15 PM EST - 3 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Mar 1, 2023, 4:30 PM EST - 3 years ago

Nephros and Donastar Announce Strategic Partnership

Feb 22, 2023, 4:30 PM EST - 3 years ago

Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

Jan 11, 2023, 7:30 AM EST - 3 years ago

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

Nov 2, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended September 30, 2022

Oct 19, 2022, 7:30 AM EDT - 3 years ago

Nephros Third Quarter 2022 Financial Results Conference Call

Oct 12, 2022, 7:30 AM EDT - 3 years ago

Nephros to Present at LD Micro Main Event XV

Oct 11, 2022, 7:30 AM EDT - 3 years ago

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

Sep 28, 2022, 7:30 AM EDT - 3 years ago

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

Sep 8, 2022, 4:00 PM EDT - 3 years ago

Nephros Appoints Joe Harris to Its Board of Directors

Aug 10, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended June 30, 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Nephros Second Quarter 2022 Financial Results Conference Call

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

May 17, 2022, 7:30 AM EDT - 4 years ago

Nephros Receives FDA 510(k) Clearance for HDF Assist Module

May 4, 2022, 4:15 PM EDT - 4 years ago

Nephros Announces Results for Quarter Ended March 31, 2022

Apr 27, 2022, 7:30 AM EDT - 4 years ago

Nephros First Quarter 2022 Financial Results Conference Call

Apr 26, 2022, 7:30 AM EDT - 4 years ago

Nephros Unveils New Branding and Website

Mar 21, 2022, 7:30 AM EDT - 4 years ago

Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Feb 23, 2022, 4:15 PM EST - 4 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results

Feb 9, 2022, 7:30 AM EST - 4 years ago

Nephros Fourth Quarter 2021 Financial Results Conference Call

Jan 13, 2022, 7:30 AM EST - 4 years ago

Nephros Issues 2022 Shareholder Letter

Jan 11, 2022, 7:30 AM EST - 4 years ago

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022

Nov 23, 2021, 4:15 PM EST - 4 years ago

Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference

Nov 8, 2021, 7:30 AM EST - 4 years ago

Nephros to Present at the Q4 Virtual Investor Summit

Nov 4, 2021, 4:15 PM EDT - 4 years ago

Nephros Announces Results for Quarter Ended September 30, 2021

Oct 21, 2021, 7:30 AM EDT - 4 years ago

Nephros Announces Third Quarter 2021 Financial Results Conference Call

Oct 8, 2021, 7:30 AM EDT - 4 years ago

Nephros Announces Preliminary Results for Third Quarter of 2021

abc12379593827 Mar. 15 at 3:34 PM

0 · Reply

NathanWolffe Mar. 15 at 2:02 PM

Watchlist monday: $AIB $NEPH $BIAF $IPM 🏆 $AIFF

0 · Reply

johnjaha Mar. 14 at 9:13 PM

$AIFF $BIAF $IPM $NEPH $AIB SRXH

1 · Reply

NathanWolffe Mar. 14 at 8:59 PM

Watchlist monday: $AIB $NEPH $BIAF $IPM 🏆 $AIFF

0 · Reply

NathanWolffe Mar. 14 at 5:00 AM

0 · Reply

StocktwitsEarnings Mar. 12 at 8:09 PM

0 · Reply

OfficialStocktwitsUser Mar. 2 at 7:45 PM

0 · Reply

BillionerOfKing Feb. 27 at 12:00 AM

$NEPH Current Stock Price: $4.01

0 · Reply

VolatilitySurface Feb. 17 at 12:23 PM

$NEPH Pre-revenue medtech; early-stage renal or dialysis focus.

0 · Reply

candletom Feb. 17 at 8:03 AM

$NEPH Micro-cap medtech or biotech; speculative

0 · Reply

VolumeDrift Feb. 9 at 2:21 PM

$NEPH Nephrology biotech; faces similar challenges to $RMTI in a specialized field.

1 · Reply

BillionerOfKing Jan. 29 at 2:26 PM

$NEPH Current Stock Price: $4.56

0 · Reply

SuperGreenToday Dec. 29 at 12:09 PM

$NEPH

0 · Reply

PrimeQuantitative Dec. 27 at 6:13 AM

$NEPH Capital seems to prefer stability in metrics rather than volatile growth spurts. Forecast reliability has room to improve materially. Evidence of repeatability could meaningfully alter perception. Without validation, volatility may persist longer than expected.

0 · Reply

Reesifer Dec. 8 at 8:52 PM

$NEPH added 4.47

0 · Reply

MatthLewis Dec. 1 at 6:50 PM

$NEPH Being in both Russell 2000 and 3000 is a huge differentiator for N/X/X/T, index inclusion means funds tied to $10T+ in AUM have to hold positions, yet we’re still talking about a company with only ~$164M market cap, $65.8M YTD revenue and a P/S near 2.5x, so I’m getting structural institutional demand on top of a high growth microgrid story at a discount

0 · Reply

MrEsKurr Nov. 26 at 6:08 AM

$NEPH if upside persist tommorow im in this baby.

0 · Reply

Oh_My_Lanta Nov. 26 at 12:46 AM

$NEPH always crazy moves

0 · Reply

stockmet Nov. 25 at 7:56 PM

$NEPH heating up 🔥

0 · Reply

Market Cap	32.52M
Revenue (ttm)	18.79M
Net Income (ttm)	1.19M
EPS (ttm)	N/A
PE Ratio	27.77
Forward PE	N/A
Profit Margin	6.33%
Debt to Equity Ratio	0.00

Volume	83,300
Avg Vol	52,646
Day's Range	N/A - N/A
Shares Out	10.64M
Stochastic %K	7%
Beta	1.42
Analysts	Strong Sell
Price Target	$7.00